S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q2 2024

Deep Track Capital

Period: Q2 2024 Β· Filed: 2024-08-14
View on SEC EDGAR β†—
AUM
$3.35B
Total portfolio value
Positions
68
Reported securities
Top Holding
AMGN
5.4% $179.7M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
AMGNAMGEN INC$179.7M5.36%$292.50$374.15+27.9%
5.4%
ARGXARGENX SE$172.0M5.13%$434.22$939.68+116.4%
5.1%
AXSMAXSOME THERAPEUTICS INC$149.2M4.45%$81.03$244.31+201.5%
4.5%
DYNDYNE THERAPEUTICS INC$141.2M4.21%$35.49$23.07-35.0%
4.2%
SWTXSPRINGWORKS THERAPEUTICS INC$139.4M4.16%β€”β€”
4.2%
INSMINSMED INC$134.0M4.00%$66.34$111.60+68.2%
4.0%
GHGUARDANT HEALTH INC$130.0M3.88%$28.26$167.98+494.4%
3.9%
DVAXDYNAVAX TECHNOLOGIES CORP$122.4M3.65%β€”β€”
3.6%
ALNYALNYLAM PHARMACEUTICALS INC$121.5M3.63%$243.32$312.78+28.6%
3.6%
NTLAINTELLIA THERAPEUTICS INC$107.4M3.21%$22.47$17.56-21.9%
3.2%
ITCIINTRA-CELLULAR THERAPIES INC$105.3M3.14%β€”β€”
3.1%
APLSAPELLIS PHARMACEUTICALS INC$95.9M2.86%$36.29β€”
2.9%
IONSIONIS PHARMACEUTICALS INC$95.3M2.85%$47.11$81.80+73.6%
2.9%
OCULOCULAR THERAPEUTIX INC$87.0M2.60%$6.66$9.64+44.7%
2.6%
FDMT4D MOLECULAR THERAPEUTICS IN$85.3M2.54%$21.34$13.00-39.1%
2.5%
ALKSALKERMES PLC$84.3M2.52%$24.39$54.58+123.8%
2.5%
NRIXNURIX THERAPEUTICS INC$83.3M2.49%$20.91$23.97+14.6%
2.5%
IMVTIMMUNOVANT INC$76.1M2.27%$27.51$38.79+41.0%
2.3%
BCYCBICYCLE THERAPEUTICS PLC$70.7M2.11%$20.29$4.35-78.6%
2.1%
PLRXPLIANT THERAPEUTICS INC$64.2M1.92%$10.86$1.17-89.2%
1.9%
TVTXTRAVERE THERAPEUTICS INC$60.6M1.81%$8.28$56.92+587.4%
1.8%
VRNAVERONA PHARMA PLC$57.8M1.73%β€”β€”
1.7%
ABVXABIVAX SA$55.3M1.65%$13.56$144.65+966.7%
1.6%
GERNGERON CORP$55.1M1.65%$4.34$1.36-68.7%
1.6%
AUTLAUTOLUS THERAPEUTICS PLC$53.1M1.59%$3.47$1.58-54.5%
1.6%
TGTXTG THERAPEUTICS INC$51.1M1.52%$18.15$53.31+193.7%
1.5%
VRDNVIRIDIAN THERAPEUTICS INC$51.0M1.52%$13.21$19.40+46.9%
1.5%
KYMRKYMERA THERAPEUTICS INC$44.8M1.34%$30.95$113.51+266.8%
1.3%
MNMDMIND MEDICINE MINDMED INC$44.0M1.31%β€”β€”
1.3%
OLMAOLEMA PHARMACEUTICALS INC$43.3M1.29%$11.14$12.64+13.5%
1.3%

Quarter-on-Quarter Activity

Q2 2024 vs. Q1 2024

New Positions (8)

TickerIssuerNotionalSince Filing
TGTXTG THERAPEUTICS INC$51.1M+193.7%
CLYMELIEM THERAPEUTICS INC$27.8M
KRROKORRO BIO INC$26.1M
ETNB89BIO INC$18.4M
INOINOVIO PHARMACEUTICALS INC$16.7M
PRAXPRAXIS PRECISION MEDICINES I$16.1M
CNTXCONTEXT THERAPEUTICS INC$14.9M
KURAKURA ONCOLOGY INC$7.9M

Exited Positions (8)

TickerIssuerNotional
TRMLTOURMALINE BIO INC$36.5M
PACBPACIFIC BIOSCIENCES CALIF IN$26.3M
NUVLNUVALENT INC$20.6M
AGENAGENUS INC$18.4M
ANABANAPTYSBIO INC$11.9M
RAREULTRAGENYX PHARMACEUTICAL IN$7.8M
MRSNMERSANA THERAPEUTICS INC$2.6M
PRMEPRIME MEDICINE INC$2.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
GPCRSTRUCTURE THERAPEUTICS INC$35.6M+2266.9%
ITCIINTRA-CELLULAR THERAPIES INC$93.2M+776.8%
IMVTIMMUNOVANT INC$60.2M+484.5%+41.0%
APLSAPELLIS PHARMACEUTICALS INC$37.1M+150.0%
IONSIONIS PHARMACEUTICALS INC$35.8M+45.6%+73.6%
SYRESPYRE THERAPEUTICS INC$-4.7M+44.8%
AXSMAXSOME THERAPEUTICS INC$45.0M+42.0%+201.5%
FDMT4D MOLECULAR THERAPEUTICS IN$-11.4M+33.8%-39.1%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
NMRACALLNEUMORA THERAPEUTICS INC.$-12.0M-82.0%
RPTXREPARE THERAPEUTICS INC$-9.7M-66.3%
VIGLVIGIL NEUROSCIENCE INC$-3.0M-62.6%
INSMINSMED INC$4.2M-58.2%+68.2%
GERNGERON CORP$-45.5M-57.4%-68.7%
APGEAPOGEE THERAPEUTICS INC$-115.0M-57.0%
SRRKSCHOLAR ROCK HLDG CORP$-9.0M-45.2%
ANIPANI PHARMACEUTICALS INC$-27.1M-43.3%
← Back to Hedge Funds